A049180 Stock Overview
A biotechnology company, provides bone graft materials, medical devices, and cosmeceuticals in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Cellumed Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,448.00 |
| 52 Week High | ₩4,440.00 |
| 52 Week Low | ₩1,402.00 |
| Beta | 0.59 |
| 11 Month Change | 2.91% |
| 3 Month Change | -19.20% |
| 1 Year Change | -64.11% |
| 33 Year Change | -86.59% |
| 5 Year Change | -79.86% |
| Change since IPO | -86.27% |
Recent News & Updates
Shareholder Returns
| A049180 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -1.3% | 16.8% | 2.2% |
| 1Y | -64.1% | 31.3% | 11.0% |
Return vs Industry: A049180 underperformed the KR Medical Equipment industry which returned 22.6% over the past year.
Return vs Market: A049180 underperformed the KR Market which returned 8.4% over the past year.
Price Volatility
| A049180 volatility | |
|---|---|
| A049180 Average Weekly Movement | 7.0% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in KR Market | 11.1% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A049180's share price has been volatile over the past 3 months.
Volatility Over Time: A049180's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 101 | In-soo Yoo | www.cellumed.co.kr |
Cellumed Co.,Ltd., a biotechnology company, provides bone graft materials, medical devices, and cosmeceuticals in South Korea. The company offers CLnZyme, a mRNA enzyme; cosmeceuticals, such as FGF7 for skin regeneration and TGFß-1 for tissue regeneration; and electric motorcycles. It provides tissue bank products, such as celluderm powder, ultra, and HD implant for the skin; patellar tendon hemi whole, posterior tibialis, anterior tibialis, semitendinosus, gracilis, and peroneus longus tendons, and meniscus lateral and medial; cancellous bone chips and cortical cancellous dental bone powders; and femoral, tibia, radius, and ulna shafts, femur distal, tibia proximal, and cervical spacer bones.
Cellumed Co.,Ltd. Fundamentals Summary
| A049180 fundamental statistics | |
|---|---|
| Market cap | ₩71.28b |
| Earnings (TTM) | -₩33.35b |
| Revenue (TTM) | ₩102.16b |
0.7x
P/S Ratio-2.1x
P/E RatioIs A049180 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A049180 income statement (TTM) | |
|---|---|
| Revenue | ₩102.16b |
| Cost of Revenue | ₩91.97b |
| Gross Profit | ₩10.19b |
| Other Expenses | ₩43.54b |
| Earnings | -₩33.35b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -677.52 |
| Gross Margin | 9.97% |
| Net Profit Margin | -32.65% |
| Debt/Equity Ratio | 35.0% |
How did A049180 perform over the long term?
See historical performance and comparison